Back to Search
CHARLES FREDRICK EISENBEIS MD
MD
Hematology & Oncology Physician
NPI: 1548217490IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
2005-01835(NC)
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1996
Research & Publications (12)
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
PMID 15447996·Clin Cancer Res·2004
3-trial
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma.
PMID 17145827·Clin Cancer Res·2006
3-trial
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism.
PMID 16341049·Leukemia·2006
4-observational
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
PMID 16076875·Blood·2005
5-case
Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12.
PMID 16314644·J Clin Oncol·2005
3-trial
IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.
PMID 15498860·Blood·2005
7-preclinical
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
PMID 15467034·J Natl Cancer Inst·2004
7-preclinical
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
PMID 12615710·Cancer Res·2003
7-preclinical
Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma?
PMID 14676100·Clin Cancer Res·2003
7-preclinical
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration.
PMID 12239141·Blood·2002
8-other
GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.
PMID 11560958·J Clin Invest·2001
7-preclinical
A case of pulmonary toxicity associated with G-CSF and doxorubicin administration.
PMID 11261324·Ann Hematol·2001
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 PARKWAY OFFICE CT STE 200
CARY, NC 27518 - Phone
- (984) 974-2150
Quick Facts
- NPI
- 1548217490
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 12
Are you this provider?
Claim Your Profile